Question of the Week — Should the Medicare Fraud Hotline or HHS OIG Reward Informants?
Opioid manufacturer Insys Therapeutics agreed to a $225 million settlement related to allegations that it unlawfully marketed its drug Subsys and paid kickbacks to providers through “speaker programs” that rewarded providers who prescribed Subsys. We previously asked whether our readers thought CEOs should be more liable for corporate wrongdoing after the Insys CEO was convicted for participating in a criminal racketeering conspiracy. The proliferation of kickback schemes, evidenced by the...